๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-03-24

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise (NCT06602141)

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿฉบ Clinical Procedure Protocol Sponsor: AdventHealth Translational Research Institute

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (9 items) and avoid the listed exclusions (48 items).

Location: AdventHealth Translational Research Institute โ€” Orlando, Florida

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Self-reported unstable body weight in the last 3 months (\> ยฑ5%);
  • Significant changes in the quality of the diet or the level of physical activity within the last 3 months;
  • Weight \>396 lb (180 kg);
  • Diagnosis of Type 1 or Type 2 diabetes mellitus;
  • Fasting blood glucose โ‰ฅ126 mg/dL;
  • HbA1c โ‰ฅ 6.5%
  • Blood pressure \>140/90 mmHg ;
  • Self-reported history or presence of the following cardiovascular conditions: congestive heart failure, coronary artery disease, significant valvular disease, congenital heart disease, serious arrhythmia, stroke, symptomatic peripheral artery disease, stable angina, myocardial infarction or coronary revascularization within 6 months; clinically significant abnormalities on ECG, presence of cardiac pacemaker, or implanted cardiac defibrillator; inability to complete the VO2max test;
  • Anemia (hemoglobin \<12 g/dl in men or 11 g/dl in women; Hct \<34%);
  • Kidney disease (creatinine \>1.6 mg/dl or estimated glomerular filtration rate \<60 mL/min/1.73m2);
  • Abnormal liver enzymes (\>2 times the upper limit of normal) that are clinically significant;

๐Ÿ” Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

๐Ÿ“ All Participating Trial Locations (2 Sites)

  • AdventHealth Translational Research Institute โ€” Orlando, Florida
  • Pennington Biomedical Research Center โ€” Baton Rouge, Louisiana

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
๐Ÿ›๏ธ View Official NIH Record โ†—